source
- AbbVie faces questions about Skyrizi competition from J&JThreats to AbbVie's immunology dominance took center stage on the company's first-quarter earnings call Wednesday morning, as analysts pressed executives on their defense strategy. The heart of the…Endpoints · 3mo ago↗ source
- FDA, AstraZeneca prep for oncology adcommThe FDA is set to convene its first advisory meeting of oncology experts in about nine months, with a couple of AstraZeneca drugs as the focus of the discussion. Details about the meeting of the ...Endpoints · 3mo ago↗ source
- Bristol Myers reaches a crossroads as a make-or-break year takes shapeBristol Myers Squibb is facing a bit of an identity crisis. CEO Chris Boerner is nearly two and a half years into his tenure, with most of his time defined byEndpoints · 3mo ago